Free Trial

Wellington Management Group LLP Grows Position in Revvity Inc. $RVTY

Revvity logo with Medical background

Key Points

  • Wellington Management Group LLP significantly increased its stake in Revvity Inc. by 238.6%, acquiring an additional 15,882 shares to own a total of 22,537 shares worth $2,384,000.
  • Revvity's stock has experienced volatility with a 1-year low of $85.12 and a high of $129.50, and the current trading price is $90.21.
  • The company reported a quarterly earnings per share (EPS) of $1.18, exceeding analyst estimates, with a revenue of $720.28 million, reflecting a 4.1% increase year-over-year.
  • MarketBeat previews top five stocks to own in October.

Wellington Management Group LLP lifted its stake in Revvity Inc. (NYSE:RVTY - Free Report) by 238.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,537 shares of the company's stock after purchasing an additional 15,882 shares during the quarter. Wellington Management Group LLP's holdings in Revvity were worth $2,384,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of RVTY. Vanguard Group Inc. grew its stake in shares of Revvity by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 14,382,849 shares of the company's stock valued at $1,521,705,000 after purchasing an additional 92,638 shares during the period. Janus Henderson Group PLC grew its stake in shares of Revvity by 0.4% during the 4th quarter. Janus Henderson Group PLC now owns 6,358,952 shares of the company's stock valued at $709,725,000 after purchasing an additional 23,650 shares during the period. EdgePoint Investment Group Inc. grew its stake in shares of Revvity by 51.1% during the 4th quarter. EdgePoint Investment Group Inc. now owns 4,058,231 shares of the company's stock valued at $452,939,000 after acquiring an additional 1,372,456 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of Revvity by 1.8% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,444,645 shares of the company's stock valued at $364,443,000 after acquiring an additional 62,307 shares during the period. Finally, Invesco Ltd. boosted its stake in Revvity by 0.8% in the 1st quarter. Invesco Ltd. now owns 1,754,859 shares of the company's stock worth $185,664,000 after purchasing an additional 13,926 shares during the period. Hedge funds and other institutional investors own 86.65% of the company's stock.

Revvity Trading Up 1.2%

NYSE:RVTY traded up $1.07 during trading hours on Friday, hitting $86.77. The company had a trading volume of 312,581 shares, compared to its average volume of 1,181,963. The company has a current ratio of 3.33, a quick ratio of 2.75 and a debt-to-equity ratio of 0.43. The company has a 50-day moving average of $93.28 and a 200 day moving average of $97.41. The company has a market cap of $10.07 billion, a P/E ratio of 36.80, a P/E/G ratio of 2.24 and a beta of 0.94. Revvity Inc. has a 1 year low of $81.36 and a 1 year high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last posted its earnings results on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.14 by $0.04. The firm had revenue of $720.28 million for the quarter, compared to analyst estimates of $711.26 million. Revvity had a return on equity of 7.66% and a net margin of 10.19%.Revvity's revenue was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.22 EPS. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. Sell-side analysts expect that Revvity Inc. will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 7th. Shareholders of record on Friday, October 17th will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Friday, October 17th. Revvity's payout ratio is currently 11.86%.

Wall Street Analysts Forecast Growth

RVTY has been the topic of several recent research reports. Raymond James Financial reaffirmed an "outperform" rating and set a $115.00 price objective (down from $120.00) on shares of Revvity in a report on Tuesday, July 29th. Evercore ISI dropped their price target on Revvity from $116.00 to $115.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Wall Street Zen downgraded Revvity from a "buy" rating to a "hold" rating in a research report on Sunday, August 3rd. Stifel Nicolaus lowered their price target on Revvity from $120.00 to $110.00 and set a "hold" rating for the company in a report on Tuesday, July 29th. Finally, Bank of America lowered their target price on Revvity from $116.00 to $110.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. Ten analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $120.07.

Read Our Latest Analysis on Revvity

About Revvity

(Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Recommended Stories

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

Should You Invest $1,000 in Revvity Right Now?

Before you consider Revvity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.

While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.